Eli Lilly and Company

LillyLilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

www.lilly.com

Eli Lilly and Company RSS Channel

Display # 
Title Published Date
Lilly Diabetes launches new Disney book for families affected by type 1 diabetes 24 September 2015
Results from the largest known cholesterol survey conducted in the U.S. 05 November 2012
Boehringer Ingelheim and Lilly introduce the My Well Planner lifestyle improvement program 13 September 2012
Lilly Diabetes launches mobile application for whose who support people with type 1 diabetes 04 September 2012
Lilly reports second-quarter 2012 results 25 July 2012
Lilly expands strategic partnership with Chinese manufacturer Novast 12 June 2012
Lilly Introduces Global 'Innovation Starts Here' Initiative to Foster Innovation and Quality Science 04 March 2012
Lilly releases its most comprehensive corporate responsibility report 14 February 2012
Fifth Lilly Oncology on Canvas Art Competition invites all touched by cancer 09 February 2012
Most couples prefer spontaneity in the bedroom 11 December 2011
Understand Barriers to Progression of Insulin Treatment 01 December 2011
Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies 24 November 2011
Lilly CEO Says Appropriate Assessment of Both Benefits and Risks Critical in Regulatory Process 02 November 2011
Lilly Reports Third-Quarter 2011 Results 21 October 2011
New Study Shows Cialis® Significantly Improved Study Endpoints 12 October 2011
Lilly Launches Open Innovation Drug Discovery Platform 29 September 2011
Lilly Invests $30 Million in Partnership to Address Non-Communicable Diseases 15 September 2011
Linagliptin Receives Approval in Europe for the Treatment of Type 2 Diabetes 26 August 2011
Lilly Announces Review of Data on Long-Term Raloxifene Treatment 10 August 2011
Lilly Global Giving Puts Power of Philanthropy in Employees' Hands 27 July 2011

Most Popular Now

Boehringer Ingelheim increases acce…

Boehringer Ingelheim is announcing an expansion of its Intellectual Property (IP) enforcement policy. The IP enforcement policy had already been amended in 2007 by an eas...

Read more

AstraZeneca licenses Zurampic to Gr…

AstraZeneca today announced that it has entered into a licensing agreement with Grünenthal GmbH for the exclusive rights to Zurampic (lesinurad) in Europe and Latin Ameri...

Read more

Exercise, future anticancer therapy…

Several studies have demonstrated the benefits of exercise to improve the quality of life of people with cancer. But Dr. Fred Saad, urologist-oncologist and researcher at...

Read more

Merck announces survey results expl…

Merck, a leading science and technology company, today announced survey results of 250 global biopharmaceutical executives on how their companies will manage new risks as...

Read more

Pfizer presents promising data from…

Pfizer Inc. (NYSE:PFE) today announced encouraging new data from a Phase 1/2 study of lorlatinib, the proposed generic name for PF-06463922, Pfizer's investigational, nex...

Read more

Promising treatment prospects for i…

In Switzerland alone, more than 5,700 women are diagnosed with breast cancer each year, and almost 1,400 of those affected die of the disease. In many very invasive forms...

Read more

Merck Accelerator expands its reach…

Merck, a leading science and technology company, has started this week the application period for the next round of its Accelerator programs in Darmstadt, Germany, and Na...

Read more

Bayer Science & Education Found…

Applications for the Bayer Science & Education Foundation's international scholarship programs are now being accepted for this year's round. In the academic sector, ambit...

Read more

New class of protein could treat ca…

A protein designed by researchers at Georgia State University can effectively target a cell surface receptor linked to a number of diseases, showing potential as a therap...

Read more

Boehringer Ingelheim and Harvard sc…

Boehringer Ingelheim today announced it has established a research collaboration with the Harvard Stem Cell Institute's - Harvard Fibrosis Network to discover new ways of...

Read more

AstraZeneca enters commercialisatio…

AstraZeneca today announced it has entered into a commercialisation agreement with Aspen Global Incorporated (AGI), part of the Aspen Group, for rights to its global anae...

Read more

Call for Abstracts: DIA EuroMeeting…

29 - 31 March 2017, Glasgow, UK. The DIA EuroMeeting 2017 provides a platform for experts from all relevant disciplines within the entire healthcare development and acce...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest World Pharma Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]